Show simple item record

dc.contributor.authorLangø, Frida Andora
dc.date.accessioned2023-07-27T10:20:39Z
dc.date.available2023-07-27T10:20:39Z
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/10832/3437
dc.description.abstractHorner syndrome is a neurological syndrome, in which the lesion along the oculosympathetic pathway can be present anywhere along the central, preganglionic or postganglionic neuron. The aetiologies of the syndrome is widely varying, but the most common causes include trauma, neoplasia, infections, iatrogenic and idiopathic cases. The main clinical signs of Horner syndrome are miosis, ptosis, enophthalmos and protrusion of the third eyelid. When recognizing these clinical signs, a pharmacological diagnosis is important for the confirmation of Horner syndrome, as the underlying neurological lesion can in worst case be life-threatening.en_US
dc.language.isoenen_US
dc.titleA comparative study of the utility of 4% cocaine and 0.5% apraclonidine in the pharmacological diagnosis of Horner syndromeen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record